Merck to Buy Immunotherapy Developer Immune Design for $300 Mln Merck to Buy Immunotherapy Developer Immune Design for $300 Mln

Merck& Co Inc said on Thursday it would buy drug developer Immune Design Corp for nearly $300 million, to gain access to its immunotherapy programs.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news